Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib in Pediatric Refractory Pontine Glioma
NCT01774253Phase 2Terminated
- Start
- May 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vismodegib in diffuse intrinsic pontine glioma (DIPG). Started May 2013; status: terminated.
02
Drugs
vismodegib
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT01774253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774253.